← SynDRA
DEFEROXAMINE
SynDRA canonical compound SYN0000822 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Mechanism of action | chelating agent |
|---|
| Indication | acute iron intoxication | iron overload |
|---|
| Disease area | hematology |
|---|
All known targets
Mechanisms of action (all sources)
Drug classes
- Iron Chelating Activity
- Iron Chelator
- Chelating Agents
- Iron Chelating Agents
- Sequestering Agents
- Siderophores
- Contrast Media
ATC classes
- V03A · ALL OTHER THERAPEUTIC PRODUCTS
Cross-references
Synonyms
- deferoxamine mesylate
- deferoxamin
- desferrioxamine
- desferrioxamine mesilate
- deferoxamine mesilate
- desferrioxamine mesylate
- Desferrioxamine
- Deferoxamina
- Desferoxamine b
- Desferrioxamine b
- Dfo-b
- NSC-527604
- Deferoxamine Mesylate
- Desferal
- deferoxamine-mesylate
- DESFERRIOXAMINE
- J06Y7MXW4D
- desferrioxamine-B
- Deferrioxamine
- Deferrioxamine B
- Deferoxamin
- Deferoxamine B
- Deferoxaminum
- Desferin
- DFOM
- Desferan
- Desferex
- Desferral
- Desferrin
- N-Benzoylferrioxamine B
- DFOA
- Ferrioxamine B, N-benzoyl-
- NSC527604
- CHEBI:4356
- Deferoximine
- Desferioximine
- Desferroxamine
- RefChem:54943
Reported adverse events
- Abdominal discomfort
- Acute respiratory distress syndrome
- Dysuria
- Hypersensitivity
- Infection
- Injection site reaction
- Mucormycosis
- Muscle spasms
- Tachycardia
- Growth retardation
Look up DEFEROXAMINE in the interactive SynDRA portal →